Image

Global Perioral Dermatitis Treatment Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Perioral Dermatitis Treatment Market, By Treatment (Immunosuppressive Agents, Topical Ivermectin, Antibiotics, Others), Diagnosis (Physical Examination, Skin Biopsy, Others), Dosage (Injection, Tablets, Ointments, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Industry Trends and Forecast to 2029.

Perioral Dermatitis Treatment Market

Global Perioral Dermatitis Treatment Market Analysis and Size

The number of cases of perioral dermatitis has risen dramatically in recent years. Perioral dermatitis is a skin condition that looks and feels like acne or rosacea. Tiny red pumps occur on the bottom part of the face in the wrinkles of the nose and around the lips in the majority of instances. Nowadays, continuously changing lifestyle results in the surging use of cosmetics, face creams, sunscreen and fluorinated toothpaste. Along with this, the prevalence rate of lifestyle or chronic diseases is high which include the growing use of topical as well as inhaled steroids. These are the causative factors increasing the risk of perioral dermatitis. Hence this led to the high demand for perioral dermatitis treatment in the market.

  • Data Bridge Market Research analyses that the perioral dermatitis treatment market was valued at USD 62 million in 2021 and is expected to reach USD 101.84 million by 2029, registering a CAGR of 6.40% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Treatment (Immunosuppressive Agents, Topical Ivermectin, Antibiotics, Others), Diagnosis (Physical Examination, Skin Biopsy, Others), Dosage (Injection, Tablets, Ointments, Others), Route of Administration (Oral, Parenteral, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

Market Players Covered

Novartis AG (Switzerland), AstraZeneca (UK), Merck & Co., Inc. (US), Sumitomo Corporation (Japan), Allergan (Ireland), LEO Pharma A/S (Denmark), Cipla Inc. (US), Eli Lilly and Company (US), Bayer AG (Germany), Abbott (US), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Johnson & Johnson Private Limited (US), Teva Pharmaceutical Industries Ltd.(Jerusalem), Sun Pharmaceutical Industries Ltd. (Mumbai), Aurobindo Pharma (Hyderabad), Lupin (Mumbai), Bausch Health Companies Inc. (Canada), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US)

Global Perioral Dermatitis Treatment Market Definition

Perioral dermatitis is a rash that affects the area around your mouth and causes inflammation. It's possible that the rash will extend up your nose or even into your eyes. Periorificial dermatitis is the term used in this situation. A scaly or red bumpy rash is the most common symptom of perioral dermatitis. Lesions on darker skin can be hyperpigmented or brown. Metronidazole cream or gel, clindamycin lotion or gel, erythromycin gel, topical sulphur formulations, and azelaic acid gel are all first-line treatments for perioral dermatitis. Antibiotics, whether used orally or topically, may be helpful for a few weeks. Azelaic acid is a prescription-only topical medication. When treatment is interrupted, the problem may reoccur, but the same therapy can be resumed as needed.

Perioral Dermatitis Treatment Market Dynamics

Drivers

  • High use of corticosteroids medications

The rise in incidence rate of chronic diseases will result in the increasing usage or corticosteroid medications which will further result in the expansion of the growth rate of the market. Topical or inhaled corticosteroids can trigger the perioral dermatitis.    

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of perioral dermatitis treatment market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness and rising use of cosmetics or personal care products containing steroids are the factors that will expand the perioral dermatitis treatment market. Other factors such as continuous changing lifestyle and advancement in treatment will positively impact the perioral dermatitis treatment market's growth rate. Additionally, high disposable income and rising incidences of hormonal imbalances will result in the expansion of perioral dermatitis treatment market. Medical history of allergies will act as a major factor influencing the growth rate of perioral dermatitis treatment market.    

Opportunities

  • Rise in the investments and research funding for perioral dermatitis treatment will flourish the growth rate

Moreover, the rise in level of investments and funds for research and development activities will boost new opportunities for the market's growth rate.

Also, advancement in medical technology and emerging new markets will provide beneficial opportunities for the perioral dermatitis treatment market in the forecast period of 2022-2029.

Restraints/Challenges Global Perioral Dermatitis Treatment Market

However, high cost associated with the available symptomatic treatment and high capital investment involved in clinical testing will impede the growth rate of perioral dermatitis treatment market. Additionally, complications linked with this condition will hinder the perioral dermatitis treatment market growth. Emergence of unfavourable conditions due to COVID-19 outbreak and lack of awareness in patients will further challenge the market in the forecast period mentioned above. The dearth of standard treatment will impede the growth rate of market.

This perioral dermatitis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on perioral dermatitis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Perioral dermatitis is most frequent in young adult females between the ages of 20 and 45. It has, however, been recorded in children. In paediatric populations, there is no substantial difference in the prevalence of perioral dermatitis by gender or race.

Perioral dermatitis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Perioral Dermatitis Treatment Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for a variety of reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of perioral dermatitis treatment in recent months.

Recent Development

  • In September, 2021, Glenmark Pharma had received the approval of U.S. Food and Drug Administration (FDA) for generic antibiotic cream named Clindamycin Phosphate Foam. It is used for the treatment of bacterial infection. Clindamycin Phosphate Foam (1%) is a generic version of Evoclin Foam by Mylan Pharmaceuticals Inc.

Global Perioral Dermatitis Treatment Market Scope

The perioral dermatitis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Immunosuppressive Agents
  • Topical Ivermectin
  • Antibiotics
  • Others

On the basis of treatment, the perioral dermatitis treatment market is segmented into immunosuppressive agents, topical ivermectin, antibiotics and others. Antibiotics segment is further segmented into topical antibiotics, and oral antibiotics. Oral antibiotics is sub-segmented into doxycycline, tetracycline, minocycline and isotretinoin. Topical antibiotics is sub-segmented into metronidazole, erythromycin and others.

Diagnosis

  • Physical Examination
  • Skin Biopsy
  • Others

On the basis of diagnosis, the perioral dermatitis treatment market is segmented into physical examination, skin biopsy and others.

Dosage

  • Injection
  • Tablets
  • Ointments
  • Others

On the basis of dosage, the perioral dermatitis treatment market is segmented into injection, tablets, ointments and others.

Route of Administration

  • Oral
  • Parenteral
  • Topical
  • Others

On the basis of route of administration, the perioral dermatitis treatment market is segmented into oral, parenteral, topical and others.

End Use

  • Clinic
  • Hospital
  • Others

On the basis of end-users, the perioral dermatitis treatment market is segmented into clinic, hospital and others.

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

The perioral dermatitis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Perioral Dermatitis Treatment Market Regional Analysis/Insights

The perioral dermatitis treatment market is analysed and market size insights and trends are provided by country, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the perioral dermatitis treatment market report are U.S., Canada and Mexico in North America, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the perioral dermatitis treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region.

Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing patient pool, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Perioral Dermatitis Treatment Market Share Analysis

The perioral dermatitis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to perioral dermatitis treatment market.

Some of the major players operating in the perioral dermatitis treatment market are:

  • Novartis AG (Switzerland)
  • AstraZeneca (UK)
  • Merck & Co., Inc. (US)
  • Sumitomo Corporation (Japan)
  • Allergan (Ireland)
  • LEO Pharma A/S (Denmark)
  • Cipla Inc. (US)
  • Eli Lilly and Company (US)
  • Bayer AG (Germany)
  • Abbott (US)
  • Pfizer Inc (US)
  • GlaxoSmithKline plc (UK)
  • Johnson & Johnson Private Limited (US)
  • Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Sun Pharmaceutical Industries Ltd. (Mumbai)
  • Aurobindo Pharma (Hyderabad)
  • Lupin (Mumbai)
  • Bausch Health Companies Inc. (Canada)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)

Research Methodology : Global Perioral Dermatitis Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-perioral-dermatitis-treatment-market

Customization Available : Global Perioral Dermatitis Treatment Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Market Value for Perioral Dermatitis Treatment Market is expected USD 101.84 million by 2029.
The Perioral Dermatitis Treatment Market is to Grow at a CAGR of 6.40% During the Forecast Period of 2022 to 2029.
Novartis AG (Switzerland), AstraZeneca (UK), Merck & Co., Inc. (US), Sumitomo Corporation (Japan), Allergan (Ireland), LEO Pharma A/S (Denmark), Cipla Inc. (US), Eli Lilly and Company (US), Bayer AG (Germany), Abbott (US) are the Major Companies Operating in Perioral Dermatitis Treatment Market.
The Countries Covered in the Perioral Dermatitis Treatment Market Report are U.S., Canada and Mexico in North America, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
The Perioral Dermatitis Treatment Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.